Literature DB >> 30295289

Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota.

Kathryn Eaton1, Ali Pirani1, Evan S Snitkin1.   

Abstract

As part of the Reproducibility Project: Cancer Biology we published a Registered Report (Eaton et al., 2015) that described how we intended to replicate selected experiments from the paper "Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota" (Arthur et al., 2012). Here we report the results. We observed no impact on bacterial growth or colonization capacity when the polyketide synthase (pks) genotoxic island was deleted from E. coli NC101, similar to the original study (Supplementary Figure 7; Arthur et al., 2012). However, for the experiment that compared inflammation, invasion, and neoplasia in azoxymethane (AOM)-treated interleukin-10-deficient mice mono-associated with NC101 or NC101[Formula: see text] pks the experimental timing of the replication attempt was longer than that of the original study. This difference was because in the original study the methodology was not clearly stated and likely led to the increased mortality and severity of inflammation observed in this replication attempt. Additionally, early death occurred during AOM treatment with higher mortality observed in NC101[Formula: see text] pks mono-associated mice compared to NC101, which was in the same direction, but more severe than the original study (Suppleme1ntal Figure 10; Arthur et al., 2012). A meta-analysis suggests that mice mono-associated with NC101[Formula: see text] pks have higher mortality compared to NC101. While these data were unable to address whether, under the conditions of the original study, NC101 and NC101[Formula: see text] pks differ in inflammation, invasion, and neoplasia this replication attempt demonstrates that clear description of experimental methods is essential to ensure accurate reproduction of experimental studies.
© 2018, Eaton et al.

Entities:  

Keywords:  E. coli; Intestinal Inflammation; Reproducibility Project: Cancer Biology; cancer biology; metascience; microbiota; mouse; replication; reproducibility

Mesh:

Substances:

Year:  2018        PMID: 30295289      PMCID: PMC6175580          DOI: 10.7554/eLife.34364

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  49 in total

Review 1.  Pathology of mouse models of intestinal cancer: consensus report and recommendations.

Authors:  Gregory P Boivin; Kay Washington; Kan Yang; Jerrold M Ward; Theresa P Pretlow; Robert Russell; David G Besselsen; Virginia L Godfrey; Tom Doetschman; William F Dove; Henry C Pitot; Richard B Halberg; Steven H Itzkowitz; Joanna Groden; Robert J Coffey
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

2.  Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice: effects of dose, route, and diet.

Authors:  Anika Bissahoyo; R Scott Pearsall; Kathleen Hanlon; Vicky Amann; Donna Hicks; Virginia L Godfrey; David W Threadgill
Journal:  Toxicol Sci       Date:  2005-09-08       Impact factor: 4.849

3.  Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype.

Authors:  Antony Cougnoux; Guillaume Dalmasso; Ruben Martinez; Emmanuel Buc; Julien Delmas; Lucie Gibold; Pierre Sauvanet; Claude Darcha; Pierre Déchelotte; Mathilde Bonnet; Denis Pezet; Harald Wodrich; Arlette Darfeuille-Michaud; Richard Bonnet
Journal:  Gut       Date:  2014-03-21       Impact factor: 23.059

4.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data.

Authors:  Heng Li
Journal:  Bioinformatics       Date:  2011-09-08       Impact factor: 6.937

5.  Prokka: rapid prokaryotic genome annotation.

Authors:  Torsten Seemann
Journal:  Bioinformatics       Date:  2014-03-18       Impact factor: 6.937

6.  Policy: NIH to balance sex in cell and animal studies.

Authors:  Janine A Clayton; Francis S Collins
Journal:  Nature       Date:  2014-05-15       Impact factor: 49.962

7.  Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria.

Authors:  Sandra C Kim; Susan L Tonkonogy; Carol A Albright; Julia Tsang; Edward J Balish; Jonathon Braun; Mark M Huycke; R Balfour Sartor
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

8.  Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis.

Authors:  Sarah Tomkovich; Ye Yang; Kathryn Winglee; Josee Gauthier; Marcus Mühlbauer; Xiaolun Sun; Mansour Mohamadzadeh; Xiuli Liu; Patricia Martin; Gary P Wang; Eric Oswald; Anthony A Fodor; Christian Jobin
Journal:  Cancer Res       Date:  2017-04-17       Impact factor: 12.701

9.  Intestinal inflammation targets cancer-inducing activity of the microbiota.

Authors:  Janelle C Arthur; Ernesto Perez-Chanona; Marcus Mühlbauer; Sarah Tomkovich; Joshua M Uronis; Ting-Jia Fan; Barry J Campbell; Turki Abujamel; Belgin Dogan; Arlin B Rogers; Jonathan M Rhodes; Alain Stintzi; Kenneth W Simpson; Jonathan J Hansen; Temitope O Keku; Anthony A Fodor; Christian Jobin
Journal:  Science       Date:  2012-08-16       Impact factor: 47.728

10.  Reducing waste from incomplete or unusable reports of biomedical research.

Authors:  Paul Glasziou; Douglas G Altman; Patrick Bossuyt; Isabelle Boutron; Mike Clarke; Steven Julious; Susan Michie; David Moher; Elizabeth Wager
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

View more
  3 in total

Review 1.  The microbiome in inflammatory bowel diseases: from pathogenesis to therapy.

Authors:  Sheng Liu; Wenjing Zhao; Ping Lan; Xiangyu Mou
Journal:  Protein Cell       Date:  2020-06-29       Impact factor: 14.870

2.  Understanding of researcher behavior is required to improve data reliability.

Authors:  Mark N Wass; Larry Ray; Martin Michaelis
Journal:  Gigascience       Date:  2019-05-01       Impact factor: 6.524

3.  Challenges for assessing replicability in preclinical cancer biology.

Authors:  Timothy M Errington; Alexandria Denis; Nicole Perfito; Elizabeth Iorns; Brian A Nosek
Journal:  Elife       Date:  2021-12-07       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.